Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment

While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.

Carl Zimmer
Author: Carl Zimmer

Written by

Carl Zimmer

in

Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Food and Drug Administration, Paxlovid (Drug), Pfizer Inc, United States
←Tauba Auerbach’s Work Might (Possibly) Have Its Own Free Will
For Jean-Yves Thibaudet, a Detour From Classical Is Business as Usual→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube